Clinical Trial Update: Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer [Phase 1]

View source ↗

Summary

Pembrolizumab is being studied in a Phase 1 trial for muscle invasive and metastatic bladder cancer; the study is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Invasive Bladder Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING